|
CIRIN Biotech is
an offshoot of CIRIN Pharmaceuticals (Pvt.) Limited. In line
with management’s focus - that is to improve quality of life
of common man - this venture is again aimed at to positively
impact the lives of less privileged ones.
 Having achieved
a sustainable & consistent growth rate in sales of
traditional drugs, CIRIN’s strategy is now to build a
portfolio of specialty products while focusing on vaccines
and biotech products.
To utilize full potential of its brand recognition – the
company has initiated the biotech project under the umbrella
of CIRIN Pharmaceuticals. A team of highly skilled and
motivated professionals has been assembled to form the CIRIN
Biotech Division.
 In-licensing of vaccines and other biotech products from
reputed manufacturers is an avenue being pursued in the
first phase. Initially imported & marketed in finished form,
these products shall subsequently be imported in bulk and
processed at CIRIN’s filling and finishing facilities.
This is a well
thought-out strategy aimed at to penetrate market at a fast
pace and secure significant market share by the time local
filling & finishing is started.
|
